Fractional picosecond 1,064 nanometer laser versus fractional radiofrequency in the treatment of acne scars: a split-face double-blinded randomized control trial
Phase 4
Recruiting
- Conditions
- Patients with acne scars (superficial and deep boxcar)fractional picosecond 1,064 nanometer laser, fractional radiofrequency, acne scars
- Registration Number
- TCTR20210730003
- Lead Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
1. Patients with acne scars (superficial and deep boxcar) at face for at least 3 months
2. Fitzpatrick skin type III-V
Exclusion Criteria
1. Patients with photosensitive dermatoses, history of skin cancer, keloid, immunodeficiency, infection/inflammation at the tested area
2. Patients who routinely smoke
3. Pregnancy
4. Receiving acne scars treatment such as AHA, retinoic acid 6 months prior to enrollment
5. Had laser or radiofrequency treatment 3 months prior to enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pore volume Baseline, 1, 3, and 6 months after treatment Antera
- Secondary Outcome Measures
Name Time Method Volume of skin depression Baseline, 1, 3, and 6 months after treatment Antera,Physician improvement scale Baseline, 1, 3, and 6 months after treatment Quartile scale,Patient improvement scale Baseline, 1, 3, and 6 months after treatment Quartile scale,Melanin index Baseline, 1, 3, and 6 months after treatment Antera,Safety Baseline, 1, 3, and 6 months after treatment Adverse event